查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392067

主动脉瓣狭窄市场：依类型、依主动脉瓣类型、严重程度、依最终用户、地区

Aortic Stenosis Market, By Type, By Aortic Valve Types (Mechanical Aortic Valves and Bioprosthetic Aortic Valves), By Severity, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球主动脉瓣狭窄市场规模预计将从 2023 年的 83.3 亿美元增至 2030 年的 167.7 亿美元，预测期内复合年增长率为 10.5%。

报告范围 报告详情
基准年 2022年 2023年市场规模 83.3亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 10.50% 2030年市场规模预测 167.7亿美元
图 1. 2023 年按地区分類的主动脉瓣狭窄全球市场占有率(%)
主动脉瓣狭窄市场-IMG1

主动脉瓣狭窄是分隔左心室和主动脉的主动脉瓣开口变窄。它阻止血液从心臟流向主动脉（主动脉），从而减少心臟主泵室每次收缩时被泵送到身体的血液量。主动脉瓣狭窄经过多年缓慢发展，阶段无症状，但随着病情变得更加严重，就会出现症状。随着瓣膜孔口变得越来越窄，心臟必须更加努力才能透过受限的瓣膜孔口泵出足够的血液，从而给心臟带来额外的压力。如果不进行治疗，最终会削弱并损害心肌。

市场动态

高血压、肥胖和糖尿病等危险因子的盛行率不断上升，对全球主动脉瓣狭窄市场的成长做出了重大贡献。主动脉瓣狭窄的常见原因包括老龄化、主动脉瓣钙沉积导致其僵硬、风湿热和主动脉瓣先天性畸形。高龄化、技术进步和意识的提高预计将在预测期内推动全球主动脉瓣狭窄市场的成长。此外，医疗保健支出的增加预计也将推动预测期内全球主动脉瓣狭窄市场的成长。经导管主动脉瓣置换术（TAVR）的扩展、新兴市场的治疗和药物开拓、个人化医疗、远端医疗和远距监测将为预测期内的全球主动脉瓣狭窄市场提供成长机会。

然而，高昂的治疗成本、限制性的报销政策、可得性和意识障碍以及临床和手术併发症预计将阻碍预测期内主动脉瓣狭窄市场的成长。

本研究的主要特点

  • 本报告对全球主动脉瓣狭窄市场进行了详细分析，并提出了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、业绩和策略等参数，介绍了全球主动脉瓣狭窄市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的资讯。
  • 全球主动脉瓣狭窄市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 透过用于分析全球主动脉瓣狭窄市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 老年人口
    • 昂贵的治疗费用
    • 经导管主动脉瓣置换术(TAVR) 扩张
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 管道分析
  • 波特的分析
  • 併购场景

第四章全球主动脉瓣狭窄市场 - 冠状冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球主动脉瓣狭窄市场，依类型，2018-2030

  • 介绍
  • 先天性主动脉瓣狭窄
  • 后天主动脉瓣狭窄

第 6 章 2018-2030 年全球主动脉瓣狭窄市场（依主动脉瓣类型）

  • 介绍
  • 机械主动脉瓣
  • 生物人工（组织）主动脉瓣

第 7 章 全球主动脉瓣狭窄市场（依严重程度），2018-2030 年

  • 介绍
  • 轻度主动脉瓣狭窄
  • 中度主动脉瓣狭窄
  • 严重主动脉瓣狭窄

第 8 章全球主动脉瓣狭窄市场，依最终用户划分，2018-2030 年

  • 介绍
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第9章2018-2030年全球主动脉瓣狭窄市场（依地区）

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 雨美国
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc
  • Braile Biomedica
  • JenaValve Technology, Inc
  • Meril Life Sciences Pvt. Ltd
  • Micro Interventional Devices, Inc
  • egnite, Inc.

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6129

The Global Aortic Stenosis Market size is expected to reach US$ 16.77 billion by 2030, from US$ 8.33 billion in 2023, at a CAGR of 10.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 8.33 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.50% 2030 Value Projection: US$ 16.77 Bn
Figure 1. Global Aortic Stenosis Market Share (%), By Region, 2023
Aortic Stenosis Market - IMG1

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Global Aortic Stenosis Market Detailed Segmentation:

  • By Type:
    • Congenital Aortic Stenosis
    • Acquired Aortic Stenosis
  • By Aortic Valve Types:
    • Mechanical Aortic Valves
    • Bioprosthetic (Tissue) Aortic Valves
  • By Severity:
    • Mild Aortic Stenosis
    • Moderate Aortic Stenosis
    • Severe Aortic Stenosis
  • By End User:
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profile:
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • Braile Biomedica
    • JenaValve Technology, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Micro Interventional Devices, Inc.
    • gnite, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Aortic Valve Types
    • Market Snapshot, By Severity
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Aging Population
    • High Cost of Treatment
    • Transcatheter Aortic Valve Replacement (TAVR) Expansion
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Pipeline Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Aortic Stenosis Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Aortic Stenosis Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Congenital Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Acquired Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Aortic Stenosis Market, By Aortic Valve Types, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Mechanical Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Bioprosthetic (Tissue) Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Aortic Stenosis Market, By Severity, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Mild Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Moderate Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Severe Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Aortic Stenosis Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Aortic Stenosis Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Lain America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CryoLife, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • JenaValve Technology, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Meril Life Sciences Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Micro Interventional Devices, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • egnite, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us